Allergy & Respiratory Research Group, Centre for Population Health Sciences, University of Edinburgh, Medical School (Doorway 3) Teviot Place, Edinburgh EH8 9AG, UK.
J R Soc Med. 2010 Mar;103(3):98-106. doi: 10.1258/jrsm.2009.090348.
Observations in the UK at the end of the last century found increasing trends of asthma prevalence over time. However, it has been reported that the number of new cases of asthma presenting to general practice has declined, especially among younger children. Aim To study national trends in the epidemiology of asthma.
A cross-sectional observation analysis was performed using the QRESEARCH database, which is one of the world's largest national aggregated health databases containing records from 422 English practices yielding 30 million patient-years of observation. Data was extracted on 333,294 individuals with a recorded diagnosis of asthma and calculated annual age-sex standardized incidence, lifetime period prevalence and asthma-related prescribing rates for each year from 2001-2005.
The incidence rate of asthma decreased in all patients (2001: 6.9 (95% confidence intervals [CI] 6.8-7.0); 2005: 5.2 (95% CI 5.1-5.3) per 1000 patient-years, p<0.001), but most particularly in children under 5 years of age (-38.4%) where a decrease in the lifetime prevalence of asthma (-34.3%) was also found. However, the lifetime prevalence rate of asthma for adults increased (15-44 years: 23.3%; 45-64 years: 27.7%; >65 years: 21.5%) with an estimated 5,658,900 (95% CI 5,639,700-5,678,200) or approximately one person in nine having being diagnosed with asthma in England. The number of asthma-related prescriptions also increased over the study period (17.1%), such that in 2005 an estimated 32,577,300 (95%CI 32,531,600-32,623,000) prescriptions were issued.
This large national study reveals that the rate of new diagnoses of asthma appears to have passed its peak; however, the number of adults with a lifetime asthma diagnosis continues to rise. Whether these trends are genuine or are a result of the introduction of incentives and guidelines to improve identification and recording of asthma or changing diagnostic trends is a question with important public health implications and one, therefore, that warrants detailed further enquiry.
上世纪末在英国的观察发现,哮喘的患病率随时间呈上升趋势。然而,据报道,到普通诊所就诊的新哮喘病例数量有所下降,尤其是在年幼的儿童中。目的:研究哮喘的流行病学的全国趋势。
使用 QRESEARCH 数据库进行横断面观察分析,该数据库是世界上最大的国家综合健康数据库之一,包含来自 422 个英国实践的记录,提供了 3000 万患者年的观察数据。对 333294 名记录有哮喘诊断的个体进行了数据提取,并计算了每年(2001-2005 年)的哮喘标准化发病率、终身期间患病率和与哮喘相关的处方率。
所有患者的哮喘发病率均下降(2001 年:6.9(95%置信区间[CI] 6.8-7.0);2005 年:5.2(95% CI 5.1-5.3)/1000 患者年,p<0.001),但在 5 岁以下儿童中下降最为显著(-38.4%),同时发现哮喘的终身患病率也下降了(-34.3%)。然而,成年人的哮喘终身患病率增加(15-44 岁:23.3%;45-64 岁:27.7%;>65 岁:21.5%),估计有 5658900 人(95%CI 5639700-5678200)或大约每九个人中就有一个人在英格兰被诊断患有哮喘。在研究期间,与哮喘相关的处方数量也有所增加(17.1%),因此,在 2005 年估计开出了 32577300 张处方(95%CI 32531600-32623000)。
这项大型全国性研究表明,新诊断的哮喘病例数量似乎已过高峰期;然而,有终身哮喘诊断的成年人数量仍在继续增加。这些趋势是真实的,还是由于提高了对哮喘的识别和记录的激励措施和指南导致,或者是由于诊断趋势的变化导致,这是一个具有重要公共卫生意义的问题,因此需要进一步详细调查。